Professional Documents
Culture Documents
Sha Li, Jin-Feng Chen, Ling-Ling Qin, Xiao-Hua Li, Zhi-Xing Cao, Yu-Cheng Gu,
Da-Le Guo & Yun Deng
To cite this article: Sha Li, Jin-Feng Chen, Ling-Ling Qin, Xiao-Hua Li, Zhi-Xing Cao, Yu-Cheng
Gu, Da-Le Guo & Yun Deng (2018): Two new sesquiterpenes produced by the endophytic fungus
Aspergillus�fumigatus from Ligusticum�wallichii, Journal of Asian Natural Products Research, DOI:
10.1080/10286020.2018.1540606
Article views: 4
1. Introduction
Natural products have played an important role in the discovery and development of
medicinal agents and endophytic fungi which live asymptomatically within the tissues
of higher plants are valuable resources for bio-activities compounds [1]. Various of
secondary metabolites such as peptides [2], polyketides [3], terpenes [4] and nitro-
gen-containing heterocycles [5] with obvious cytotoxicity had been isolated from
endophytic fungi. With the purpose of searching novel compounds with cytotoxicity
from endophytes of traditional Chinese medicine (TCM), Aspergillus fumigatus has
been isolated from the root of Ligusticum wallichii. The chemical investigation of its
fermentation broth led to the isolation of two previously undescribed sesquiterpenes,
fumagillene A (1) and B (2) Figure 1, along with nine known compounds (3–11).
Details of the isolation, structure elucidation, and cytotoxicity of new compounds are
discussed below.
the absolute configuration of 1 was established as 1R,30 R. It was given a trivial name
as fumagillene A.
Compound 2 had the same molecular formula as 1 (C15H24O2), which was
deduced from HRESIMS. On comparing the 1D- and 2D-NMR spectra of 2 with
those of 1, it appeared that they might be a pair of cis-trans isomer. The NOESY cor-
relation between H-10 (d 1.74) and H-6 (d 2.59–2.67) was observed and indicated the
“E” configuration of the double bond between C-10 and C-5 (Figure 3). The experi-
mental ECD spectrum of 2 was in accordance with the calculated ECD spectrum for
(1R,30 R)-2 (Figure 4), establishing the assignment of the absolute configuration of 2
as (R,E)-5-((R)-3-hydroxy-6-methylhept-5-en-2-ylidene)-2-methylenecyclohexan-1-ol
and compound 2 was named fumagillene B.
The nine known compounds were identified as gliotoxin (3) [6], 5a,6-dihydrobis-
dethio-3,10a-bis(methylthio)gliotoxin (4) [7], verruculogen (5) [8], 12,13-dihydroxyfu-
mitremorgin C (6) [8], fumiquinazoline A (7) [9], cyclo-((S)-Pro-(R)-Val) (8) [10],
pseurotin A (9) [11], cyclo-((S)-Pro-(R)-Ile) (10) [12], and cephalimysin A (11) [13]
on the basis of the NMR and MS spectroscopic comparison with those reported in
the literatures.
MTT method was applied to evaluate the cytotoxicity of novel compounds against
MDA-ME-231 and MV4-11 cancer cell lines. Compound 1 showed moderate growth
inhibition against MV4-11 and MDA-ME-231 with IC50 values of 8.4 ± 2.9 lg/ml and
14.3 ± 5.8 lg/ml. Compound 2 showed moderate growth inhibition against MV4-11
and MDA-ME-231 with IC50 values of 11.2 ± 3.6 lg/ml and 17.3 ± 6.4 lg/ml.
4 S. LI ET AL.
3. Experimental
3.1. General experimental procedures
Optical rotations were determined on a Perkin-Elmer-241 polarimeter (Perkin Elmer,
Inc., Waltham, MA) at room temperature. UV spectra were recorded on a Perkin-
Elmer Lambda 35 UV-VIS spectrophotometer (Perkin Elmer, Inc.). IR spectra were
measured by Perkin-Elmer one FT-IR spectrometer (KBr) (Perkin Elmer, Inc.). CD
spectra were recorded on a Chirascan circular dichroism spectrometer (Applied
Photophysics Ltd, Leatherhead, UK). 1D and 2D NMR were carried out on a Bruker-
Ascend-400 MHz instrument (Bruker, Bremen, Germany) at 300 K, with TMS as
internal standard. HRESIMS were measured using a Synapt G2 HDMS instrument
(Waters Corporation Milford, MA). Preparative HPLC was performed on a NP7000
serials pump (Hanbon Sci. & Tech., Jiangsu, China) equipped with a Kromasil RP-
C18 column (10 250 mm, 5 lm, Akzo Nobel Pulp and Performance Chemicals AB,
Bohus, Sweden) using a NU3000 serials UV detector (Hanbon Sci. & Tech). Column
chromatography (CC) was performed with silica gel (200–300 mesh, Qingdao
Haiyang Chemical Co., Qingdao, China) and Sephadex LH-20 (GE-Healthcare Bio-
Sciences AB, Uppsala, Sweden). All the solvent used were of analytical grade.
Table 1. 1H and 13
C NMR spectral data of 1 and 2.a
1 2
Position dH (J in Hz) dC dH (J in Hz) dC
1 4.14, dd (6.6, 4.0) 73.4 4.15, dd (8.1, 4.1) 72.8
2 – 150.3 – 150.4
3 2.07–2.16, m; 2.36–2.46, m 32.5 2.07–2.19, m; 2.31–2.43, m 33.0
4 2.09–2.20, m; 2.27–2.37, m 31.7 2.10–2.22, m; 2.33–2.43, m 34.6
5 – 131.2 – 130.6
6 2.39–2.48, m; 2.49–2.57, m 38.7 2.24–2.32, m; 2.59–2.67, m 40.4
7 4.82, s; 4.93, s 108.1 4.80, s; 4.92, s 106.9
10 1.73, s 12.0 1.74, s 12.0
20 – 131.3 – 131.2
30 4.64, dd (7.6, 6.7) 70.0 4.70, t (7.2) 70.7
40 2.10–2.20, m; 2.33–2.42, m 33.8 2.10–2.24, m; 2.31–2.41, m 30.3
50 5.04–5.12, m 120.4 5.05–5.12, m 120.1
60 – 134.6 – 135.2
70 1.71, s 26.0 1.71, s 26.1
80 1.64, s 18.1 1.64, s 18.1
a
400 MHz for 1H and 100 MHz for 13
C in CDCl3.
MeOH-H2O, 60:40, 3 ml/min, tR: 25.2 min) and 4 (5.7mg, wavelength: 220 nm, MeOH-
H2O, 55:45, 3 ml/min, tR: 37.8 min), Fr.2 (0.47g) was purified by a preparative HPLC
using a reversed-phase column to afford 7 (4.2 mg, wavelength: 220 nm, MeOH-H2O,
40:60, 3 ml/min, tR: 25.3 min). The fractions eluted with 90:10 were combined (2.52g)
and further subjected to Sephadex LH-20 column chromatography (4 180 cm;
CHCl3-MeOH, 1:1) afforded three subfractions (Fr.1–Fr.3). Fr.1 (1.45g) was purified
by a preparative HPLC using a reversed-phase column to afford 5 (6.2 mg, wavelength:
220 nm, MeOH-H2O, 65:35, 3 ml/min, tR: 28.3 min) and 6 (7.3 mg, wavelength:
220 nm, MeOH-H2O, 60:40, 3 ml/min, tR: 25.2 min), Fr.2 (0.53g) was purified by a pre-
parative HPLC using a reversed-phase column to afford 9 (5.2 mg, wavelength:
220 nm, MeOH-H2O, 65:35, 3 ml/min, tR: 22.3 min). The fractions eluted with 85:15
were combined (1.07g) and further subjected to Sephadex LH-20 column chromatog-
raphy (4 180 cm; CHCl3-MeOH, 1:1) afforded three subfractions (Fr.1–Fr.3). Fr.1
(0.60 g) was purified by a preparative HPLC using a reversed-phase column to afford
10 (23.1 mg, wavelength: 210 nm, MeOH-H2O, 30:70, 3 ml/min, tR: 15.3 min) and 11
(4.2 mg, wavelength: 220 nm, MeOH-H2O, 65:35, 3 ml/min, tR: 23.5 min), Fr.3 (0.33g)
was purified by a preparative HPLC using a reversed-phase column to afford 8
(20.7 mg, wavelength: 210 nm, MeOH-H2O, 30:70, 3 ml/min, tR: 15.5 min).
Disclosure statement
No potential conflict of interest was reported by the authors.
Acknowledgments
The authors wish to thank Dr. Jing Yang (Kunming Institute of Botany, Chinese Academy of
Sciences) for the help in ECD calculation.
Funding
This research was funded by Sichuan Provincial Youth Science and Technology Innovation
Team (2016TD0006, 2015TD0028); China Postdoctoral Science Foundation (2017M622985).
References
[1] R.N. Kharwar, A. Mishra, S.K. Gond, A. Stierle, and D. Stierle, Nat. Prod. Rep. 28, 1208
(2011).
[2] J.X. Zhan, A.M. Burns, M.P.X. Liu, S.H. Faeth, and A.A.L. Gunatilaka, J. Nat. Prod. 70,
227 (2007).
[3] A.H. Aly, R. Edrada-Ebel, I.D. Indriani, V. Wray, W.E.G. Muller, F. Totzke, U.
Zirrgiebel, C. Schachtele, M.H.G. Kubbutat, and W.H. Lin, J. Nat. Prod. 71, 972 (2008).
[4] M. Isaka, P. Chinthanom, T. Boonruangprapa, N. Rungjindamai, and U. Pinruan, J.
Nat. Prod. 73, 683 (2010).
[5] C.M. Cui, X.M. Li, C.S. Li, P. Proksch, and B.G. Wang, J. Nat. Prod. 73, 729 (2010).
[6] V.T. Nguyen, J.S. Lee, Z.J. Qian, Y.X. Li, K.N. Kim, S.J. Heo, Y.J. Jeon, W.S. Park, I.W.
Choi, J.Y. Je, and W.K. Jung, Mar. Drugs. 12, 69 (2013).
[7] M. Okamoto, K. Yoshida, I. Uchida, M. Nishikawa, M. Kohsaka, and H. Aoki, Chem.
Pharm. Bull. 34, 340 (1986).
[8] S.S. Afiyatullov, A.I. Kalinovskii, M.V. Pivkin, P.S. Dmitrenok, and T.A. Kuznetsova,
Chem. Nat. Compd. 40, 615 (2004).
[9] C. Takahashi, T. Matsushita, M. Doi, K. Minoura, T. Shingu, Y. Kumeda, and A.
Numata, J. Chem. Soc. Perkin Trans. 1. 18, 2345 (1995).
[10] M. Adamczeski, A.R. Reed, and P. Crews, J. Nat. Prod. 58, 201 (1995).
[11] C.M. Boot, N.C. Gassner, J.E. Compton, K. Tenney, C.M. Tamble, R.S. Lokey, and T.R.
Holman, J. Nat. Prod. 70, 1672 (2007).
[12] B. Yang, J.D. Dong, X.F. X.W. Zhou, K.J. Lee, L.S. Wang, S. Zhang, and Y.H. Liu, Helv.
Chim. Acta. 92, 1112 (2009).
[13] T. Yamada, E. Imai, K. Nakatuji, A. Numata, and R. Tanaka, Tetrahedron Lett. 48,
6294 (2007).
[14] L.N. Wang, L.L. Qin, J.L. He, X.H. Li, Z.X. Cao, Y.C. Gu, F. Deng, and Y. Deng, J.
Asian Nat. Prod. Res. 26, 1 (2018).